Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 1.3x - 1.4x | 1.4x |
| Selected Fwd Ps Multiple | 0.5x - 0.5x | 0.5x |
| Fair Value | €4 - €4.42 | €4.21 |
| Upside | 75.3% - 93.7% | 84.5% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Cantourage Group SE | - | XTRA:HIGH |
| Apontis Pharma AG | - | XTRA:APPH |
| Labiana Health, S.A. | - | DB:8RK |
| Krka, d. d. | - | LJSE:KRKG |
| Eevia Health Oyj | - | NGM:EEVIA |
| Biofrontera AG | - | DB:B8FK |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| HIGH | APPH | 8RK | KRKG | EEVIA | B8FK | |||
| XTRA:HIGH | XTRA:APPH | DB:8RK | LJSE:KRKG | NGM:EEVIA | DB:B8FK | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | NM- | 3.9% | 5.8% | 5.0% | 4.9% | 8.8% | ||
| 3Y CAGR | NM- | -1.8% | -0.2% | 6.8% | -36.0% | 2.0% | ||
| Latest Twelve Months | 63.1% | 31.1% | 10.1% | 5.7% | -61.2% | -36.5% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 1.5% | -5.6% | -7.2% | 19.1% | -50.5% | -25.6% | ||
| Prior Fiscal Year | 1.5% | -30.6% | -14.7% | 17.4% | -19.2% | -171.6% | ||
| Latest Fiscal Year | 2.3% | 1.6% | -7.4% | 18.7% | -111.6% | -1.1% | ||
| Latest Twelve Months | 11.3% | 1.6% | -1.8% | 18.7% | -111.6% | -2.0% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | NA | 22.3x | 6.7x | 8.8x | -3.7x | -3.0x | ||
| Price / LTM Sales | 29.2x | 1.9x | 0.3x | 2.7x | 0.3x | 0.8x | ||
| LTM P/E Ratio | 258.8x | 123.3x | -17.0x | 14.4x | -0.3x | -41.9x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 0.3x | 1.9x | 29.2x | |||||
| Historical LTM P/S Ratio | 0.9x | 3.0x | 8.1x | |||||
| Selected Price / Sales Multiple | 1.3x | 1.4x | 1.4x | |||||
| (x) LTM Sales | 18 | 18 | 18 | |||||
| (=) Equity Value | 24 | 25 | 26 | |||||
| (/) Shares Outstanding | 6.1 | 6.1 | 6.1 | |||||
| Implied Value Range | 3.91 | 4.11 | 4.32 | |||||
| FX Rate: EUR/EUR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 3.91 | 4.11 | 4.32 | 2.28 | ||||
| Upside / (Downside) | 71.3% | 80.3% | 89.3% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | HIGH | APPH | 8RK | KRKG | EEVIA | B8FK | |
| Value of Common Equity | 57 | 93 | 19 | 5,156 | 1 | 14 | |
| (/) Shares Outstanding | 12.5 | 8.3 | 7.0 | 30.6 | 67.1 | 6.1 | |
| Implied Stock Price | 4.59 | 11.15 | 2.68 | 168.50 | 0.01 | 2.28 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | |
| Implied Stock Price (Trading Cur) | 4.59 | 11.15 | 2.68 | 168.50 | 0.10 | 2.28 | |
| Trading Currency | EUR | EUR | EUR | EUR | SEK | EUR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 0.09 | 1.00 | |